Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Experimental Orofacial Medicine, Philipps University Marburg, Marburg, Germany.
J Biomed Mater Res B Appl Biomater. 2017 Nov;105(8):2603-2611. doi: 10.1002/jbm.b.33795. Epub 2016 Oct 12.
This study assesses the biocompatibility of novel silk protein membranes with and without modification, and evaluates their effect on facilitating bone formation and defect repair in guided bone regeneration. Two calvarian bone defects 12 mm in diameter were created in each of a total of 38 rabbits. Four different types of membranes, (silk-, hydroxyapatite-modified silk-, β-TCP-modified silk- and commonly clinically used collagen-membranes) were implanted to cover one of the two defects in each animal. Histologic analysis did not show any adverse tissue reactions in any of the defect sites indicating good biocompatibility of all silk protein membranes. Histomorphometric and histologic evaluation revealed that collagen and β-TCP modified silk membranes supported bone formation (collagen: bone area fraction p = 0.025; significant; β-TCP modified silk membranes bone area fraction: p = 0.24, not significant), guided bone regeneration and defect bridging. The bone, which had formed in defects covered by β-TCP modified silk membranes, displayed a more advanced stage of bone tissue maturation with restoration of the original calvarial bone microarchitecture when compared to the bone which had formed in defects, for which any of the other test membranes were used. Micro-CT analysis did not reveal any differences in the amount of bone formation between defects with and without membranes. In contrast to the collagen membranes, β-TCP modified silk membranes were visible in all cases and may therefore be advantageous for further supporting bone formation beyond 10 weeks and preventing soft tissue ingrowth from the periphery. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 2603-2611, 2017.
本研究评估了新型丝蛋白膜的生物相容性,包括未经修饰和经过修饰的膜,并评价了它们在引导骨再生中促进骨形成和缺损修复的效果。在总共 38 只兔子中,每只兔子的两侧颅骨各创建了两个直径为 12mm 的骨缺损。将四种不同类型的膜(丝蛋白膜、羟基磷灰石修饰丝蛋白膜、β-TCP 修饰丝蛋白膜和临床上常用的胶原膜)分别植入每只动物的两个缺损中的一个,以覆盖其中一个缺损。组织学分析显示,所有丝蛋白膜在任何缺损部位均未引起任何不良的组织反应,表明其具有良好的生物相容性。组织形态计量学和组织学评价表明,胶原和β-TCP 修饰丝蛋白膜支持骨形成(胶原:骨面积分数 p=0.025;有统计学意义;β-TCP 修饰丝蛋白膜的骨面积分数:p=0.24,无统计学意义),引导骨再生和缺损桥接。与使用其他测试膜的骨缺损相比,用β-TCP 修饰丝蛋白膜覆盖的骨缺损中形成的骨具有更成熟的骨组织成熟阶段,并且恢复了原始颅骨的骨微结构。微 CT 分析未显示有膜和无膜骨缺损之间骨形成量的差异。与胶原膜相反,在所有情况下均可见到β-TCP 修饰丝蛋白膜,因此它可能有利于在 10 周后进一步支持骨形成并防止来自周边的软组织向内生长。© 2016 Wiley Periodicals, Inc. J 生物材料 Res 部分 B:应用生物材料,105B:2603-2611,2017。